Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DNA TOPOISOMERASES' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 235 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Dominguez, I; Pastor, N; Mateos, S; Cortes, F
      Testing the SCE mechanism with non-poisoning topoisomerase II inhibitors

      MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    2. Chavalitshewinkoon-Petmitr, P; Pongvilairat, G; Ralph, RK; Denny, WA; Wilairat, P
      Inhibitory effects of 9-anilinoacridines on Plasmodium falciparum gametocytes

      TROPICAL MEDICINE & INTERNATIONAL HEALTH
    3. Hooper, DC
      Emerging mechanisms of fluoroquinolone resistance

      EMERGING INFECTIOUS DISEASES
    4. Lin, DM; Chen, TY; Wang, LF; Hui, CF; Hwang, J
      Characterization of drug resistance to VM-26 in A2780 ovarian carcinoma cells

      ZOOLOGICAL STUDIES
    5. Okamoto, R; Takano, H; Sekikawa, T; Tanaka, T; Toyada, M; Ukon, K; Tanimoto, K; Kumazaki, T; Nishiyama, M
      Unique action determinants of double acting topoisomerase inhibitor, TAS-103

      INTERNATIONAL JOURNAL OF ONCOLOGY
    6. Mekapati, SB; Hansch, C
      Comparative QSAR studies on bibenzimidazoles and terbenzimidazoles inhibiting topoisomerase I

      BIOORGANIC & MEDICINAL CHEMISTRY
    7. Zhao, LX; Kim, TS; Ahn, SH; Kim, TH; Kim, EK; Cho, WJ; Choi, H; Lee, CS; Kim, JA; Jeong, TC; Chang, CJ; Lee, ES
      Synthesis, topoisomerase I inhibition and antitumor cytotoxicity of 2,2 ':6 ',2 ''-, 2,2 ': 6 ',3 ''- and 2,2 : 6 ',4 ''-terpyridine derivatives

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    8. Stewart, AJ; Mistry, P; Dangerfield, W; Bootle, D; Baker, M; Kofler, B; Okiji, S; Baguley, BC; Denny, WA; Charlton, PA
      Antitumor activity of XR5944, a novel and potent topoisomerase poison

      ANTI-CANCER DRUGS
    9. Matsumoto, Y; Takano, H; Nagao, S; Fojo, T
      Altered topoisomerase II alpha and multidrug resistance-associated proteinlevels during drug selection: Adaptations to increasing drug pressure

      JAPANESE JOURNAL OF CANCER RESEARCH
    10. Bielawski, K; Bielawska, A; Wolczynski, S
      Aromatic extended bisamidines: Synthesis, inhibition of topoisomerases, and anticancer cytotoxicity in vitro

      ARCHIV DER PHARMAZIE
    11. Ivanova, LV; Rudolph, P; Shilov, YM; Gieseler, F; Alm, P; Tareeva, IE; Proppe, D
      Correlation between the expression of DNA topoisomerases I and II alpha and clinical parameters in kidney disease

      AMERICAN JOURNAL OF KIDNEY DISEASES
    12. Lucas, I; Germe, T; Chevrier-Miller, M; Hyrien, O
      Topoisomerase II can unlink replicating DNA by precatenane removal

      EMBO JOURNAL
    13. Gopal, YNV; Kondapi, AK
      Topoisomerase II poisoning by indazole and imidazole complexes of ruthenium

      JOURNAL OF BIOSCIENCES
    14. Mokdsi, G; Harding, MM
      Inhibition of human topoisomerase II by the antitumor metallocenes

      JOURNAL OF INORGANIC BIOCHEMISTRY
    15. Uggla, B; Mollgard, L; Stahl, E; Mossberg, LL; Karlsson, MG; Paul, C; Tidefelt, U
      Expression of topoisomerase II alpha in the G0/G1 cell cycle phase of fresh leukemic cells

      LEUKEMIA RESEARCH
    16. Slesarev, AI; Belova, GI; Lake, JA; Kozyavkin, SA
      Topoisomerase V from Methanopyrus kandleri

      HYPERTHERMOPHILIC ENZYMES, PT C
    17. Huang, CH; Treat, J
      New advances in lung cancer chemotherapy: Topotecan and the role of topoisomerase I inhibitors

      ONCOLOGY
    18. Morris, RE; Aird, RE; Murdoch, PD; Chen, HM; Cummings, J; Hughes, ND; Parsons, S; Parkin, A; Boyd, G; Jodrell, DI; Sadler, PJ
      Inhibition of cancer cell growth by ruthenium(II) arene complexes

      JOURNAL OF MEDICINAL CHEMISTRY
    19. Lisby, M; Olesen, JR; Skouboe, C; Krogh, BO; Straub, T; Boege, F; Velmurugan, S; Martensen, PM; Andersen, AH; Jayaram, M; Westergaard, O; Knudsen, BR
      Residues within the N-terminal domain of human topoisomerase I play a direct role in relaxation

      JOURNAL OF BIOLOGICAL CHEMISTRY
    20. Aguilar-Mahecha, A; Hales, BF; Robaire, B
      Expression of stress response genes in germ cells during spermatogenesis

      BIOLOGY OF REPRODUCTION
    21. Berger, SJ; Gupta, S; Belfi, CA; Gosky, DM; Mukhtar, H
      Green tea constituent (-)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    22. Feister, HA; Onyia, JE; Miles, RR; Yang, X; Galvin, R; Hock, JM; Bidwell, JP
      The expression of the nuclear matrix proteins NuMA, topoisomerase II-alpha, and -beta in bone and osseous cell culture: Regulation by parathyroid hormone

      BONE
    23. Russell, LB; Hunsicker, PR; Hack, AM; Ashley, T
      Effect of the topoisomerase-II inhibitor etoposide on meiotic recombination in male mice

      MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    24. Hofland, K; Petersen, BO; Falck, J; Helin, K; Jensen, PB; Sehested, M
      Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex

      CLINICAL CANCER RESEARCH
    25. Rangarajan, M; Kim, JS; Jin, S; Sim, SP; Liu, A; Pilch, DS; Liu, LF; LaVoie, EJ
      2 ''-substituted 5-phenylterbenzimidazoles as topoisomerase I poisons

      BIOORGANIC & MEDICINAL CHEMISTRY
    26. Rangarajan, M; Kim, JS; Sim, SP; Liu, A; Liu, LF; LaVoie, EJ
      Topoisomerase I inhibition and cytotoxicity of 5-bromo- and 5-phenylterbenzimidazoles

      BIOORGANIC & MEDICINAL CHEMISTRY
    27. Rappa, G; Shyam, K; Lorico, A; Fodstad, O; Sartorelli, AC
      Structure-activity studies of novobiocin analogs as modulators of the cytotoxicity of etoposide (VP-16)

      ONCOLOGY RESEARCH
    28. Neale, MH; Charlton, PA; Cree, IA
      Ex vivo activity of XR5000 against solid tumors

      ANTI-CANCER DRUGS
    29. Franchitto, A; Pichierri, P; Mosesso, P; Palitti, F
      Catalytic inhibition of topoisomerase II in Werner's syndrome cell lines enhances chromosomal damage induced by X-rays in the G2 phase of the cell cycle

      INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
    30. Gieseler, F; Clark, M; Stiebeling, K; Puschmann, M; Valsamas, S
      Induction of apoptosis by idarubicin: how important is the plasma peak?

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    31. Hirata, S; Katoh, O; Oguri, T; Watanabe, H; Yajin, K
      Expression of drug resistance-related genes in head and neck squamous cellcarcinoma and normal mucosa

      JAPANESE JOURNAL OF CANCER RESEARCH

    32. TAS-103 - Oncolytic topoisomerase inhibitor

      DRUGS OF THE FUTURE
    33. Etievant, C; Kruczynski, A; Barret, JM; Perrin, D; van Hille, B; Guminski, Y; Hill, BT
      F 11782, a dual inhibitor of topoisomerases I and II with an original mechanism of action in vitro, and markedly superior in vivo antitumour activity, relative to three other dual topoisomerase inhibitors, intoplicin, aclarubicin and TAS-103

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    34. Minderman, H; Wrzosek, C; Cao, SS; Utsugi, T; Kobunai, T; Yamada, Y; Rustum, YM
      Mechanism of action of the dual topoisomerase-I and -II inhibitor TAS-103 and activity against (multi)drug resistant cells

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    35. Miettinen, HE; Jarvinen, TAH; Kellner, U; Kauraniemi, P; Parwaresch, R; Rantala, I; Kalimo, H; Paljarvi, L; Isola, J; Haapasalo, H
      High topoisomerase II alpha expression associates with high proliferation rate and and poor prognosis in oligodendrogliomas

      NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
    36. Darcy, IK; Sumners, DW
      Rational tangle distances on knots and links

      MATHEMATICAL PROCEEDINGS OF THE CAMBRIDGE PHILOSOPHICAL SOCIETY
    37. Ji, SC
      Free energy and information contents of Conformons in proteins and DNA

      BIOSYSTEMS
    38. Rappa, G; Murren, JR; Johnson, LM; Lorico, A; Sartorelli, AC
      Novobiocin-induced VP-16 accumulation and MRP expression in human leukemiaand ovarian carcinoma cells

      ANTI-CANCER DRUG DESIGN
    39. Mizushina, Y; Iida, A; Ohta, K; Sugawara, F; Sakaguchi, K
      Novel triterpenoids inhibit both DNA polymerase and DNA topoisomerase

      BIOCHEMICAL JOURNAL
    40. Li, Q; Mitscher, LA; Shen, LL
      The 2-pyridone antibacterial agents: Bacterial topoisomerase inhibitors

      MEDICINAL RESEARCH REVIEWS
    41. Shpitz, B; Bomstein, Y; Zehavi, T; Bernheim, J; Liverant, S; Kaufman, Z; Buklan, G; Klein, E
      Topoisomerase II alpha expression in ductal carcinoma in situ of the breast: A preliminary study

      HUMAN PATHOLOGY
    42. Mirski, SEL; Voskoglou-Nomikos, T; Young, LC; Deeley, RG; Campling, BG; Gerlach, JH; Cole, SPC
      Simultaneous quantitation of topoisomerase II alpha and beta isoform mRNAsin lung tumor cells and normal and malignant lung tissue

      LABORATORY INVESTIGATION
    43. Satherley, K; de Souza, L; Neale, MH; Alexander, RA; Myatt, N; Foss, AJE; Hungerford, JL; Hickson, ID; Cree, IA
      Relationship between expression of topoisomerase II isoforms and chemosensitivity in choroidal melanoma

      JOURNAL OF PATHOLOGY
    44. Goswami, PC; Sheren, J; Albee, LD; Parsian, A; Sim, JE; Ridnour, LA; Higashikubo, R; Gius, D; Hunt, CR; Spitz, DR
      Cell cycle-coupled variation in topoisomerase II alpha mRNA is regulated by the 3 '-untranslated region - Possible role of redox-sensitive protein binding in mRNA accumulation

      JOURNAL OF BIOLOGICAL CHEMISTRY
    45. Edwards, TK; Saleem, A; Shaman, JA; Dennis, T; Gerigk, C; Oliveros, E; Gartenberg, MR; Rubin, EH
      Role for nucleolin/Nsr1 in the cellular localization of topoisomerase I

      JOURNAL OF BIOLOGICAL CHEMISTRY
    46. Declais, AC; Marsault, J; Confalonieri, F; de La Tour, CB; Duguet, M
      Reverse gyrase, the two domains intimately cooperate to promote positive supercoiling

      JOURNAL OF BIOLOGICAL CHEMISTRY
    47. Bhaduri, T; Basak, S; Sikder, D; Nagaraja, V
      Inhibition of Mycobacterium smegmatis topoisomerase I by specific oligonucleotides

      FEBS LETTERS
    48. Satterwhite, DJ; White, RL; Matsunami, N; Neufeld, KL
      Inhibition of topoisomerase II alpha expression by transforming growth factor-beta 1 is abrogated by the papillomavirus E7 protein

      CANCER RESEARCH
    49. Hopfner, R; Mousli, M; Jeltsch, JM; Voulgaris, A; Lutz, Y; Marin, C; Bellocq, JP; Oudet, P; Bronner, C
      ICBP90, a novel human CCAAT binding protein, involved in the regulation oftopoisomerase II alpha expression

      CANCER RESEARCH
    50. Valkov, NI; Gump, JL; Engel, R; Sullivan, DM
      Cell density-dependent VP-16 sensitivity of leukaemic cells is accompaniedby the translocation of topoisomerase II alpha from the nucleus to the cytoplasm

      BRITISH JOURNAL OF HAEMATOLOGY
    51. Pommier, Y; Pourquier, P; Urasaki, Y; Wu, JX; Laco, GS
      Topoisomerase I inhibitors: selectivity and cellular resistance

      DRUG RESISTANCE UPDATES
    52. Spaltmann, F; Lohrmann, E; Ziegelbauer, K
      A target-specific cellular assay for screening of topoisomerase I inhibitors

      JOURNAL OF BIOMOLECULAR SCREENING
    53. Wu, L; Karow, JK; Hickson, ID
      Genetic recombination: Helicases and topoisomerases link up

      CURRENT BIOLOGY
    54. van Hille, B; Perrin, D; Hill, BT
      Differential in vitro interactions of a series of clinically useful topoisomerase-interacting compounds with the cleavage/religation activity of the human topoisomerase II alpha and II beta isoforms

      ANTI-CANCER DRUGS
    55. Pastor, N; Pinero, J; Ortiz, T; Mateos, JC; De Miguel, M; Cortes, F
      Topoisomerase activities and levels in irradiated Chinese hamster AA8 cells and in its radiosensitive mutant EM9

      INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
    56. Ohyama, T; Li, Y; Utsugi, T; Irie, S; Yamada, Y; Sato, T
      A dual topoisomerase inhibitor, TAS-103, induces apoptosis in human cancercells

      JAPANESE JOURNAL OF CANCER RESEARCH
    57. Turnbull, RM; Meczes, EL; Rogers, MP; Lock, RB; Sullivan, DM; Finlay, GJ; Baguley, BC; Austin, CA
      Carbamate analogues of amsacrine active against non-cycling cells: relative activity against topoisomerases II alpha and beta

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    58. Ng, SW; Liu, Y; Hasselblatt, KT; Mok, SC; Berkowitz, RS
      A new human topoisomerase III that interacts with SGS1 protein

      NUCLEIC ACIDS RESEARCH
    59. Broccoli, S; Marquis, JF; Papadopoulou, B; Olivier, M; Drolet, M
      Characterization of a Leishmania donovani gene encoding a protein that closely resembles a type IB topoisomerase

      NUCLEIC ACIDS RESEARCH
    60. Nagao, T; Yoshimura, S; Saito, Y; Imai, K
      Developmental toxicity of the topoisomerase inhibitor, etoposide, in rabbits after intravenous administration

      TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS
    61. Kim, R; Ohi, Y; Inoue, H; Toge, T
      Expression and relationship between topoisomerase I and II a genes in tumor and normal tissues in esophageal, gastric and colon cancers

      ANTICANCER RESEARCH
    62. Ramakrishnan, T; Chandrasekhar, P
      The control of tuberculosis: a continuous game of snakes and ladders

      JOURNAL OF BIOSCIENCES
    63. Breault, GA; Hunter, CA; Mayers, PC
      Supramolecular topology

      TETRAHEDRON
    64. Mongelli, E; Romano, A; Desmarchelier, C; Coussio, J; Ciccia, G
      Cytotoxic 4-nerolidylcatechol from Pothomorphe peltata inhibits topoisomerase I activity

      PLANTA MEDICA
    65. Bhat, UG; Raychaudhuri, P; Beck, WT
      Functional interaction between human topoisomerase II alpha and retinoblastoma protein

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    66. Yakubovskaya, EA; Gabibov, AG
      Topoisomerases: Mechanisms of DNA topological alterations

      MOLECULAR BIOLOGY
    67. Wang, X; Watt, PM; Borts, RH; Louis, EJ; Hickson, ID
      The topoisomerase II-associated protein, Pat1p, is required for maintenance of rDNA locus stability in Saccharomyces cerevisiae

      MOLECULAR AND GENERAL GENETICS
    68. Lopez-Garcia, P
      DNA supercoiling and temperature adaptation: A clue to early diversification of life?

      JOURNAL OF MOLECULAR EVOLUTION
    69. Redinbo, MR; Stewart, L; Champoux, JJ; Hol, WGJ
      Structural flexibility in human topoisomerase I revealed in multiple non-isomorphous crystal structures

      JOURNAL OF MOLECULAR BIOLOGY
    70. Bouille, P; Subra, F; Mouscadet, JF; Auclair, C
      Antisense-mediated repression of RNA topoisomerase II expression leads to an impairment of HIV-1 replicative cycle

      JOURNAL OF MOLECULAR BIOLOGY
    71. Ma, ZK; Chu, DTW; Cooper, CS; Li, Q; Fung, AKL; Wang, SY; Shen, LL; Flamm, RK; Nilius, AM; Alder, JD; Meulbroek, JA; Or, YS
      Synthesis and antimicrobial activity of 4H-4-Oxoquinolizine derivatives: Consequences of structural modification at the C-8 position

      JOURNAL OF MEDICINAL CHEMISTRY
    72. Walowsky, C; Fitzhugh, DJ; Castano, IB; Ju, JY; Levin, NA; Christman, MF
      The topoisomerase-related function gene TRF4 affects cellular sensitivity to the antitumor agent camptothecin

      JOURNAL OF BIOLOGICAL CHEMISTRY
    73. Del Poeta, M; Toffaletti, DL; Rude, TH; Dykstra, CC; Heitman, J; Perfect, JR
      Topoisomerase I is essential in Cryptococcus neoformans: Role in pathobiology and as an antifungal target

      GENETICS
    74. Asis, SE; Bruno, AM; Martinez, AR; Sevilla, MV; Gaozza, CH; Romano, AM; Coussio, JD; Ciccia, G
      Diarylsemicarbazones: synthesis, antineoplastic activity and topoisomeraseI inhibition assay

      FARMACO
    75. Hooper, DC
      Mode of action of fluoroquinolones

      DRUGS
    76. RAMIREZSANTOYO R; LOPEZSWIDERSKI A; AVALOSDIAZ E; HERRERAESPARZA R
      THE EXPRESSION AND LOCALIZATION OF SCL-70 DNA TOPOISOMERASE-I VARY THROUGHOUT THE CELL-CYCLE/

      Revue du rhumatisme
    77. SUI ZH; ALTOM J; NGUYEN V; FERNANDEZ J; BERNSTEIN JI; HILIARD JJ; BARRETT JF; PODLOGAR BL; OHEMENG KA
      SYNTHESIS AND INHIBITORY ACTIVITY OF NOVEL TRICYCLIC AND TETRACYCLIC QUINOLINES AGAINST TOPOISOMERASES

      Bioorganic & medicinal chemistry
    78. KIM JS; SUN Q; YU C; LIU A; LIU LF; LAVOIE EJ
      QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS ON 5-SUBSTITUTED TERBENZIMIDAZOLES AS TOPOISOMERASE-I POISONS AND ANTITUMOR AGENTS

      Bioorganic & medicinal chemistry
    79. DOLAN ME; FRYDMAN B; THOMPSON CB; DIAMOND AM; GARBIRAS BJ; SAFA AR; BECK WT; MARTON LJ
      EFFECTS OF 1,2-NAPHTHOQUINONES ON HUMAN TUMOR-CELL GROWTH AND LACK OFCROSS-RESISTANCE WITH OTHER ANTICANCER AGENTS

      Anti-cancer drugs
    80. HAYASHI M; ICHIKAWA Y; ARAI S; ENDOH D; OKUI T
      HIGHER SENSITIVITY IN LEC RAT-CELLS TO A TOPOISOMERASE-II INHIBITOR, ELLIPTICINE

      Journal of veterinary medical science
    81. FERGUSON LR; TURNER PM; HART DW; TINDALL KR
      AMSACRINE-INDUCED MUTATIONS IN AS52 CELLS

      Environmental and molecular mutagenesis
    82. MASUDA N; MATSUI K; NEGORO S; TAKIFUJI N; TAKEDA K; YANA T; KOBAYASHI M; HIRASHIMA T; KUSUNOKI Y; USHIJIMA S; KAWASE I; TADA T; SAWAGUCHI H; FUKUOKA M
      COMBINATION OF IRINOTECAN AND ETOPOSIDE FOR TREATMENT OF REFRACTORY OR RELAPSED SMALL-CELL LUNG-CANCER

      Journal of clinical oncology
    83. ROBERT J; LARSEN AK
      DRUG-RESISTANCE TO TOPOISOMERASE-II INHIBITORS

      Biochimie
    84. Lee, HK; Lee, DS; Lim, J; Kim, JS; Im, KS; Jung, JH
      Topoisomerase I inhibitors from the Streptomyces sp. strain KM86-9B isolated from a marine sponge

      ARCHIVES OF PHARMACAL RESEARCH
    85. Miller, MC; Stineman, CN; Vance, JR; West, DX; Hall, IH
      The cytotoxicity of copper(II) complexes of 2-acetyl-pyridyl-N-4-substituted thiosemicarbazones

      ANTICANCER RESEARCH
    86. TSEDINH YC
      BACTERIAL AND ARCHEAL TYPE-I TOPOISOMERASES

      Biochimica et biophysica acta, N. Gene structure and expression
    87. BAGULEY BC; FERGUSON LR
      MUTAGENIC PROPERTIES OF TOPOISOMERASE-TARGETED DRUGS

      Biochimica et biophysica acta, N. Gene structure and expression
    88. HAMMONDS TR; MAXWELL A; JENKINS JR
      USE OF A RAPID THROUGHPUT IN-VIVO SCREEN TO INVESTIGATE INHIBITORS OFEUKARYOTIC TOPOISOMERASE-II ENZYMES

      Antimicrobial agents and chemotherapy
    89. NASH HA
      PROTEIN-STRUCTURE - TOPOLOGICAL NUTS AND BOLTS

      Science
    90. MOREIRA D; LOPEZGARCIA P
      SYMBIOSIS BETWEEN METHANOGENIC ARCHAEA AND DELTA-PROTEOBACTERIA AS THE ORIGIN OF EUKARYOTES - THE SYNTROPHIC HYPOTHESIS

      Journal of molecular evolution
    91. FANG M; WU HY
      SUPPRESSION OF LEU-500 MUTATION IN TOPA-TYPHIMURIUM STRAINS - THE PROMOTER RELAY AT WORK( SALMONELLA)

      The Journal of biological chemistry
    92. SABOURIN M; BYL JAW; HANNAH SE; NITISS JL; OSHEROFF N
      A MUTANT YEAST TOPOISOMERASE-II (TOP2G437S) WITH DIFFERENTIAL SENSITIVITY TO ANTICANCER DRUGS IN THE PRESENCE AND ABSENCE OF ATP

      The Journal of biological chemistry
    93. FANG M; WU HY
      A PROMOTER RELAY MECHANISM FOR SEQUENTIAL GENE ACTIVATION

      Journal of bacteriology
    94. BOJANOWSKI K; INGBER DE
      IONIC CONTROL OF CHROMOSOME ARCHITECTURE IN LIVING AND PERMEABILIZED CELLS

      Experimental cell research
    95. Grigolo, B; Mazzetti, I; Borzi, RM; Hickson, ID; Fabbri, M; Fasano, L; Meliconi, R; Facchini, A
      Mapping of topoisomerase II alpha epitopes recognized by autoantibodies inidiopathic pulmonary fibrosis

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    96. JARVINEN TAH; HOLLI K; KUUKASJARVI T; ISOLA JJ
      PREDICTIVE VALUE OF TOPOISOMERASE II-ALPHA AND OTHER PROGNOSTIC FACTORS FOR EPIRUBICIN CHEMOTHERAPY IN ADVANCED BREAST-CANCER

      British Journal of Cancer
    97. PERRIN D; VANHILLE B; HILL BT
      DIFFERENTIAL SENSITIVITIES OF RECOMBINANT HUMAN TOPOISOMERASE-II-ALPHA AND TOPOISOMERASE-II-BETA TO VARIOUS CLASSES OF TOPOISOMERASE-II INTERACTING AGENTS

      Biochemical pharmacology
    98. MEDDERS WM; WOOLEY RE; GIBBS PS; SHOTTS EB; BROWN J
      MUTATION-RATE OF AVIAN INTESTINAL COLIFORM BACTERIA WHEN PRESSURED WITH FLUOROQUINOLONES

      Avian diseases
    99. LARSEN AK; GOBERT C; GILBERT C; MARKOVITS J; BOJANOWSKI K; SKLADANOWSKI A
      DNA TOPOISOMERASES AS REPAIR ENZYMES - MECHANISM(S) OF ACTION AND REGULATION BY P53

      Acta Biochimica Polonica
    100. JIANG WD; GERHOLD D; KMIEC EB; HAUSER M; BECKER JM; KOLTIN Y
      THE TOPOISOMERASE-I GENE FROM CANDIDA-ALBICANS

      Microbiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/21 alle ore 03:29:03